External light irradiation is usually required in bacterial infection theranostics; however, it is always accompanied by limited light penetration, imaging interference, and incomplete bacterial destruction. Herein, a feasible “image‐launching therapy” strategy is developed to integrate real‐time optical imaging and simultaneous photodynamic therapy (PDT) of bacterial infections into persistent luminescence (PL) nanoparticles (NPs). Mesoporous silica NPs are used as a substrate for in situ deposition of PL nanodots of ZnGa2O4:Cr3+ to obtain mPL NPs, followed by surface grafting with silicon phthalocyanine (Si‐Pc) and electrostatic assembly of cyanine 7 (Cy7) to fabricate mPL@Pc‐Cy NPs. The PL emission of light‐activated mPL@Pc‐Cy NPs is quenched by Cy7 assembly at physiological conditions through the fluorescence resonance energy transfer effect, but is rapidly restored after disassembly of Cy7 in response to bacterial infections. The self‐illuminating capabilities of NPs avoid tissue autofluorescence under external light irradiation and achieve real‐time colorimetric imaging of bacterial infections. In addition, the afterglow of mPL NPs can persistently excite Si‐Pc photosensitizers to promote PDT efficacy for bacterial elimination and accelerate wound full recovery with normal histologic features. Thus, this study expands the theranostic strategy for precise imaging and simultaneous non‐antibiotic treatment of bacterial infections without causing side effects to normal tissues.